Evaluate the role of Singhasyadi Kwatha in the management of Gout

CLINICAL EVALUATION OF THE ROLE OF SINGHASYADI KWATHA IN THE MANAGEMENT OF VATA-RAKTA(GOUT)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047494

Enrollment

Registered

2022-11-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either sex in the age group between 20-70 years 2.Diagnosed and confirmed case of Vatarakta(Gout) 3.Patients having serum uric acid level more than 6 mg/dl with or without any associated features like joint inflammation 4.Willing to participate and able to provide signed informed consent

Exclusion criteria

Exclusion criteria: 1.Patients below 20 years and above 70 years of age. 2.Patients suffering with other forms of Arthritis like Rheumatoid Arthritis, Ankylosing Spondylitis, Infective Arthritis, Osteoarthritis etc. 3.Pregnant and lactating mother. 4.Patients having any malignancy or any other severe systemic disorders.

Design outcomes

Primary

Measure	Time frame
Effectiveness SINGHASYADI KWATHA in the management OF Vatarakta of various etiological factorsTimepoint: 45 days for each patients and completion of trial within 6 months from the date of starting of trial	—

Secondary

Measure	Time frame
To evaluate safety, sustainability and adverse drug reaction of trial drugTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Pooja rani

University Post Graduate Institute of Ayurveda Studies and Research jodhpur

bkmudgal9@gmail.com9460318138

Outcome results